CFO interim
Emergent BioSolutions Inc. names Frank Vargo interim CFO
Emergent BioSolutions Inc. reported in a Form 8-K filed October 16, 2026 that Frank Vargo was named interim Interim Chief Financial Officer, effective January 1, 2027.
In the filing's words
The Company has appointed Frank Vargo, Vice President, Treasurer, to serve as the Company’s Interim Chief Financial Officer and principal financial and accounting officer beginning on January 1, 2027.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Emergent BioSolutions Inc. (EBS) |
|---|---|
| Event | Interim |
| Incoming | Frank Vargo |
| Outgoing | Richard Lindahl |
| Title in the filing | Interim Chief Financial Officer |
| Effective | January 1, 2027 |
| 8-K filed | October 16, 2026 |
| Internal promotion | Yes |
| Prior role (per filing) | Vice President, Treasurer, Emergent BioSolutions Inc. |
| SEC CIK | 0001367644 |
Emergent BioSolutions Inc. reported this change in a Form 8-K, Item 5.02, filed October 16, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-10-16
Something wrong about Frank Vargo? Send a correction with the primary source.